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Summary
 
Vitamin A supplementation reduces child mortality in populations at risk of
vitamin A deficiency and may also reduce maternal mortality. One possible
explanation for this is that vitamin A deficiency is associated with altered
immune function and cytokine dysregulation. Vitamin A deficiency in preg-
nancy may thus compound the pregnancy-associated bias of cellular immune
responses towards Th-2-like responses and exacerbate susceptibility to
intracellular pathogens. We assessed mitogen and antigen-induced cytokine
responses during pregnancy and lactation in Ghanaian primigravidae receiv-
ing either vitamin A supplementation or placebo. This was a double-blind,
randomized, placebo-controlled trial of weekly vitamin A supplementation in
pregnant and lactating women. Pregnancy compared to postpartum was asso-
ciated with a suppression of cytokine responses, in particular of the proin-
flammatory cytokines interferon (IFN)-
 
γ
 
 and tumour necrosis factor (TNF)-
 
α
 
. Mitogen-induced TNF-
 
α
 
 responses were associated with a decreased risk of
peripheral parasitaemia during pregnancy. Furthermore, vitamin A supple-
mentation was significantly associated with an increased ratio of mitogen-
induced proinflammatory cytokine (IFN-
 
γ
 
) to anti-inflammatory cytokine
(IL-10) during pregnancy and in the postpartum period. The results of this
study indicate that suppression of proinflammatory type 1 immune responses
and hence immunity to intracellular infections, resulting from the combined
effects of pregnancy and vitamin A deficiency, might be ameliorated by vita-
min A supplementation.
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Introduction
 
In animals, vitamin A deficiency is associated with alter-
ations in the balance of type 1 (proinflammatory) to type 2
or type 3 (non-inflammatory or anti-inflammatory) cytok-
ine responses and can lead to inappropriate responses to
infection [1,2]. If similar immune dysregulation occurs in
humans, the ability to control infections such as toxoplas-
mosis, tuberculosis, leishmaniasis and malaria, where the
cytokine balance is crucial to control of the infection, may be
compromised [3–8]. To date, relatively few studies have
attempted to assess how vitamin A status affects immune
function in humans. However, there is substantial evidence
from community trials in young children that vitamin A
supplementation is associated with large reductions in child
mortality 
 
−
 
 mainly from infectious causes 
 
−
 
 [9] and a trial of
maternal vitamin A supplementation in Nepal reported a
44% reduction in all cause maternal mortality [10]. Data
from studies designed to assess markers of cell-mediated
immunity in individuals with vitamin A deficiency have
tended to support evidence from animal studies that vitamin
A deficiency is associated with a bias towards type 1 immune
responses [11,12], but the studies are somewhat unrepresen-
tative as they were conducted in individuals with underlying
immune deficiencies. In otherwise healthy women, vitamin
A deficiency has been associated with increased markers of
inflammation in breast milk, but these were not reversed by
vitamin  A  supplementation  [13,14].  A  study  in  vitamin
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A-deficient but otherwise healthy children in Indonesia gave
ambiguous results, as vitamin A deficiency was associated
with a type 1 bias in the steady state but also with reduced
production of interferon (IFN)-
 
γ
 
 after antigen stimulation
[15].
During pregnancy a delicate balance between type 1 and
type 2 or type 3 immune responses is required to maintain
tolerance of the antigenically foreign fetus while continuing
to provide protection from infection [16]. Proinflammatory
immune responses can damage the placenta leading to pla-
cental insufficiency and premature delivery or low birth
weight babies; in successful pregnancies anti-inflammatory
cytokines are secreted at the materno–fetal interface [16–18].
On the other hand, suppression of type 1 responses to
commonly encountered antigens [19–22] may explain the
increased risk of infection with intracellular pathogens dur-
ing pregnancy [23]. The accumulated evidence suggests that
vitamin A deficiency, and consequently vitamin A supple-
mentation, during pregnancy is likely to disturb this balance,
but the outcome is impossible to predict from available data.
Thus, if vitamin A supplementation promotes anti-
inflammatory immune responses this might increase the risk
of infection; alternatively, if vitamin A supplementation pro-
motes proinflammatory responses it might increase the risk
of poor birth outcomes. As there are currently two large
intervention trials investigating the effects of vitamin A sup-
plementation on maternal morbidity and mortality in Bang-
ladesh and Ghana, we felt that it was important to evaluate
the impact of vitamin A supplementation on cellular
immune responses in pregnant and lactating women.
 
Subjects, materials and methods
 
Study design
 
Study subjects were pregnant primigravid women enrolled
in a randomized, double-blind, placebo-controlled trial of
vitamin A supplementation and immunity to pregnancy-
associated malaria, the details of which are reported else-
where [24]. At enrollment, 51% (45/89) of women were mar-
ginally vitamin A-deficient (plasma retinol 
 
<
 
30 
 
µ
 
g/dl), while
15% were deficient (
 
<
 
 20 
 
µ
 
g/dl). Mild to moderate anaemia
(plasma Hb 
 
<
 
11 g/dl) was common [86% (83/97)] but
severe anaemia (
 
<
 
 7 g/dl) was observed in only 7%. Women
were recruited from antenatal clinics at Nkoranza District
Hospital and three rural health clinics, in Brong Ahafo
region, Central Ghana, during the period March–June 2001.
Women were assigned randomly, using balanced block ran-
domization (eight women/block), to receive weekly vitamin
A (10 000 IU as retinyl palmitate in groundnut oil, plus toco-
pherol as a preservative) or placebo (groundnut oil plus
tocopherol) from enrollment until 6 weeks postpartum.
Fieldworkers delivered supplements to women, in person
each week, and directly observed their consumption. Primi-
gravid women were eligible for inclusion in the study if they
were pregnant (as assessed by urine test or palpation), resi-
dent within the study area, in good health and less than
approximately 24 weeks pregnant, as determined by fundal
height measurements. In practice, fundal height estimates
were inaccurate and gestational ages at recruitment were
thus recalculated at the end of the study from known dates of
full term deliveries. According to available health records,
none of the women were suffering from clinical HIV infec-
tion or tuberculosis but diagnostic tests were not performed.
The estimated prevalence of HIV infection in pregnant Gha-
naian women in the Brong Ahafo region for 2000 was 1.6%
[25]. Individual informed consent was obtained from all
study participants.
Enrollment of 35 women into each arm of the study was
calculated to give 90% power at the 5% level to detect a two-
fold difference in mean cytokine responses between the vita-
min A and placebo groups.
Ethical approval for the study was obtained from the eth-
ics committees of the London School of Hygiene and Trop-
ical Medicine and the Ghanaian Ministry of Health.
 
Laboratory assays
 
Venous blood samples (4 ml) were collected into heparinized
vacutainers (Greiner, Labortechnik, Austria) on three occa-
sions from each woman: at enrolment (
 
n
 
 
 
=
 
 50 in the placebo
group, 
 
n
 
 
 
=
 
 48 in the vitamin A group), in late pregnancy
(
 
n
 
 
 
=
 
 43 in the placebo group, 
 
n
 
 
 
=
 
 45 in the vitamin A group)
and at 6 weeks postpartum (
 
n
 
 
 
=
 
 49 in the placebo group,
 
n
 
 
 
=
 
 46 in the vitamin A group). At the same time, finger-
prick blood samples were obtained for assessment of plasma
haemoglobin (Hb) concentrations (HemoCue, Ångelholm,
Sweden) and determination of malarial parasitaemia by
microscopic examination of Giemsa-stained thick blood
films. Plasma retinol was measured in baseline samples by
high performance liquid chromatography using standard
methods [26] from plasma stored in UV-protected vials for a
maximum of 5 months at 
 
−
 
30
 
°
 
C.
 
Whole blood culture
 
Whole blood assays were carried out as described previously.
Although this method does not allow for cytokine responses
to be standardized by the number of leucocytes per well, this
assay has been shown previously not to be sensitive to nor-
mal variation in leucocyte numbers [27,28]. In brief, blood
was diluted 1 : 10 with RPMI-1640 tissue culture medium
(Invitrogen, Paisley, UK), containing 100 U/ml of penicillin
and streptomycin and 0·002 
 
M l
 
-glutamine (Invitrogen) and
aliquoted (180 
 
µ
 
l) into 96-well flat-bottomed tissue culture
plates (SLS Ltd, Nottingham, UK). Twenty 
 
µ
 
l of purified
protein derivative (PPD) of 
 
Mycobacterium tuberculosis
 
(Statens Serum Institute, Copenhagen, Denmark), phyto-
haemaglutinin (PHAp; Sigma, Dorset, UK) or tissue culture
medium (negative control) were added to replicate wells to
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give a final concentration of 1 
 
µ
 
g/ml and cultures were incu-
bated at 37
 
°
 
C in 5% CO
 
2
 
 for 1, 3 or 6 days. Aliquots of cul-
ture supernatant (150 
 
µ
 
l) were removed from wells on day 1
for assessment of tumour necrosis factor (TNF)-
 
α
 
, day 3 for
interleukin (IL)-10 and day 6 for interferon (IFN)-
 
γ
 
, based
on previous data of optimum yields using the same whole
blood culture method [28,29]. Samples were stored at 
 
−
 
40
 
°
 
C
until required.
 
Cytokine immunoassays
 
Supernatants were shipped to the United Kingdom and anal-
ysed for IFN-
 
γ
 
, TNF-
 
α
 
 and IL-10 using a sandwich enzyme-
linked immunosorbent asay (ELISA) technique with com-
mercially available monoclonal antibodies (Pharmingen,
Oxford, UK) as described [30]. The lower limits of detection
(LLD) were 62 pg/ml for IL-10 and 125 pg/ml for IFN-
 
γ
 
 and
TNF-
 
α
 
. The upper limit of detection (ULD) was 3000 pg/ml;
samples containing more than 3000 pg/ml cytokine were
retested at a 1 : 25 dilution, resulting in an ULD of 75 000 pg/
ml. A positive-control supernatant was tested on each ELISA
plate; coefficients of variation between plates were 12% for
IL-10, 7·7% for IFN-
 
γ
 
 in response to PHA, 18·5% for IFN-
 
γ
 
in response to PPD and 36% for TNF-
 
α
 
. Samples were
grouped and tested by time of collection (enrolment, late
pregnancy and postpartum) to minimize variation between
the treatment groups.
 
Statistical analysis
 
Statistical analysis was performed in Stata 8 (Stata Corpora-
tion, Texas, USA). Cytokine responses were categorized as
either detectable (
 
≥
 
 LLD) or non-detectable (
 
<
 
 LLD) and
analysed by logistic regression or, where a sufficient propor-
tion of the values were within the detection limits, analysed
by linear regression of logarithmically transformed data,
censored for values that lay outside the detection limits (i.e.
the model accepts them as being somewhere between 0 and
the LLD, or more than the ULD). For samples where both
values lay within the detection limits of the assay, log
 
e
 
 ratios
of cytokine concentrations were calculated and analysed by
linear regression. Analyses assessing changes in cytokine
concentrations due to pregnancy status were performed in
the placebo group only, by linear regression of values within
the detection limits, and robust standard errors to account
for repeated measurements within individuals. We hypothe-
sized that vitamin A supplementation could affect immune
responses differently in pregnancy and postpartum and
therefore effects of vitamin A supplementation were assessed
in two separate models: at late pregnancy, with responses
controlled for those at enrolment in early pregnancy; and at
postpartum, with responses controlled for those at late preg-
nancy. As the number of doses of vitamin A or placebo varied
depending on gestational age at enrolment, analyses were
initially stratified by the number of doses received at late
pregnancy (7–11, 12–16 or 17–26) and at postpartum (15–
25, 26–38). However, as no evidence of a dose–response
effect was observed, results are presented for all groups
combined.
 
Results
 
The study was designed to assess the effect of pregnancy on
cytokine responses to a mitogen (PHA) and an antigen
(PPD) and to determine the effect of vitamin A supple-
mentation on these during pregnancy and postpartum.
Table 1 shows baseline characteristics of the two groups.
Although mean levels of most variables were similar there
was a marked difference between the groups in educational
level. Nutritional status at baseline (as indicated by the vari-
ables reported in Table 1) was similar in the two treatment
groups. Gestational ages, back-calculated from recorded ges-
tational age at delivery, ranged from 4 to 29 weeks (median
 
=
 
 16 weeks) at enrolment and 25–36 weeks (median 
 
=
 
31 weeks) at the late pregnancy blood collection and did not
 
Table 1.
 
Baseline characteristics of women allocated randomly to 
receive vitamin A supplementation or placebo.
Variable Placebo (
 
n
 
 
 
=
 
 50) Vitamin A (
 
n
 
 
 
=
 
 48)
Mean plasma retinol 
 
µ
 
g/dl (s.d.)
30·6 (9·1) 
 
n
 
 
 
=
 
 47 28·5 (11·1) 
 
n
 
 
 
=
 
 42
Mean haemoglobin g/dl
(s.d.)
9·76 (1·6) 
 
n
 
 
 
=
 
 50 9·26 (1·3) 
 
n
 
 
 
=
 
 47
Mean BMI (kg/m
 
2
 
) (s.d.) 21·3 (1·8) 
 
n
 
 
 
=
 
 49 21·2 (2·0) 
 
n
 
 
 
=
 
 48
Mean MUAC (cm) (s.d.) 26·4 (2·6) 
 
n
 
 
 
=
 
 50 25·8 (2·0) 
 
n
 
 
 
=
 
 47
Mean age (years) (s.d.) 21·0 (2·9) 
 
n
 
 
 
=
 
 50 21·0 (2·9) 
 
n
 
 
 
=
 
 48
Mean gestational age
(weeks) (s.d.)
 
1
 
15·0 (5·6) 
 
n
 
 
 
=
 
 50 17·0 (4·3) 
 
n
 
 
 
=
 
 48
Peripheral parasitaemia 18/46 (39%) 20/44 (45%)
Temperature 
 
>
 
 37·4
 
°
 
C 22/50 (44%) 17/48 (35%)
Recruited in peak malaria
transmission
 
2
 
33/50 (64%) 31/48 (65%)
Resident in Nkoranza
town
33/50 (66%) 31/48 (65%)
Level of education
None 9/48 2/47
Primary 7/48 7/47
Junior 28/48 26/47
Secondary 4/48 12/47
Enrolment
 
3
 
Early 20/46 10/42
Mid 15/46 20/42
Late 11/46 12/42
 
1
 
Gestation was estimated by palpation and measurement of fundal
height. 
 
2
 
Although malarial transmission was perennial, transmission
peaked in the months at the end and after the two rainy seasons.
 
3
 
Enrolment. Women who enrolled at different times during their preg-
nancies had different numbers of weeks between the data collections at
enrolment and late pregnancy: early, more than 16 weeks; mid, 12–
16 weeks; late, 7–11 weeks. BMI: body mass index; MUAC: mid-upper-
arm circumference.
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differ significantly between the treatment groups. Compli-
ance was uniformly high, with 99·1% of all scheduled doses
of vitamin A or placebo being received. Women who enrolled
earlier in their pregnancies had a greater number of total
weekly doses of vitamin A or placebo and these were similar
between the treatment groups, ranging from 16 to 37
(median 
 
=
 
 27) for the vitamin A supplementation group and
15–38 (median 
 
=
 
 24) for the placebo group.
 
Cytokine responses to PHA and PPD are suppressed 
during pregnancy
 
Proportions of women with detectable cytokine responses
(i.e. 
 
>
 
 LLD) were assessed at the three time-points 
 
−
 
 enrolment in early pregnancy, late pregnancy and 6 weeks
postpartum (Table 2). Cells from the majority of women
made detectable IFN-
 
γ
 
 and IL-10 responses to the mitogen
PHA but fewer made detectable levels of TNF-
 
α
 
. The pro-
portions of detectable responses to PPD were lower than for
PHA, especially for TNF-
 
α
 
 and IL-10.
Comparisons of the proportions of detectable responses at
the three time-points within the vitamin A-supplemented
and placebo groups indicated strong evidence of an effect of
pregnancy status. The proportions of detectable responses to
PHA for all tested cytokines were significantly lower in late
pregnancy than in either early pregnancy or at postpartum
(
 
P 
 
<
 
 0·01). The proportions of detectable responses to PPD
were reduced in both early and late pregnancy compared to
postpartum (
 
P < 0·01) and were reduced further in late com-
pared to early pregnancy, reaching statistical significance for
IFN-γ (P < 0·001).
Analysis of the effect of pregnancy status on the levels of
positive cytokine responses was performed in the placebo
group only (Table 3). Concentrations of IFN-γ and IL-10
decreased in early and late pregnancy compared to postpar-
tum; for IFN-γ and TNF-α, levels were lowest in late preg-
nancy while for IL-10 levels were lowest in early pregnancy.
Furthermore, pregnancy-associated suppression of cytokine
concentrations was more marked for IFN-γ than for either
TNF-α or IL-10.
The differences in the extent of suppression of the differ-
ent cytokine responses prompted us to assess the effect of
pregnancy on the ratios of cytokine responses to PHA
(Table 3). As expected, the ratio of IFN-γ to IL-10 was sig-
nificantly lower in both early and late pregnancy compared
to postpartum. In contrast, the ratio of TNF-α : IL-10 was
highest in early pregnancy and lowest in late pregnancy. The
ratio between the two proinflammatory cytokines IFN-γ and
TNF-α was reduced significantly in both early and late
pregnancy compared to postpartum, indicating that IFN-γ
responses are more severely suppressed during pregnancy
than TNF-α responses.
Levels of mitogen-induced TNF-α but not IFN-γ or 
IL-10 were associated with peripheral parasitaemia
There was no association between peripheral parasitaemia
and IFN-γ or IL-10 responses at any of the time-points tested
(data not shown). However, lower TNF-α responses were
observed in women with peripheral parasitaemia during
pregnancy but not postpartum. At enrolment in early preg-
nancy, peripheral parasitaemia (36/84) was associated non-
significantly with a decreased likelihood of a detectable
response to PHA (OR = 0·34, P = 0·06) and in those with a
detectable response, lower levels of TNF-α (29% lower,
P = 0·06). In a multivariable analysis controlling for an effect
of plasma retinol and other factors (see below), the presence
of peripheral parasitaemia was associated with 40% lower
TNF-α concentrations (P = 0·01). In late pregnancy the
presence of peripheral parasitaemia (26/85), controlling for
vitamin A supplementation, was associated with 36% lower
TNF-α concentrations (P = 0·05), while the ratio of TNF-
α : IL-10 was non-significantly lower (37%, P = 0·11) in
those with peripheral parasitaemia. There was no evidence of
Table 2. Prevalence of detectable cytokine responses in whole blood assays after stimulation with phytohaemagglutinin (PHA) or purified protein 
derivative (PPD).
Responses to PHA
N > LLD/total samples (%)
Responses to PPD
N > LLD/total samples (%) 
IFN-γ TNF-α IL-10 IFN-γ TNF-α IL-10
Placebo group
Early pregnancy 46/46 (100%) 39/46 (85%) 48/48 (100%) 23/43 (54%)‡ 3/46 (7%)‡ 7/48 (15%)‡
Late pregnancy 37/39 (95%)† 24/40 (60%)† 38/42 (90%)† 17/41 (42%)‡ 0/40 (0%)‡ 2/42 (5%)‡
Postpartum 44/44 (100%) 32/44 (73%) 45/45 (100%) 35/44 (80%) 18/44 (41%) 18/44 (41%)
Vitamin A supplemented group
Early pregnancy 46/46 (100%) 37/48 (77%) 48/48 (100%) 32/47 (68)‡ 2/47 (4%)‡ 4/48 (8%)‡
Late pregnancy 43/45 (96%)† 24/44 (55%)† 40/44 (91%)† 17/45 (38)‡§ 1/44 (2%)‡ 2/43 (5%)‡
Postpartum 44/45 (98%) 36/42 (86%) 46/46 (100%) 38/47 (81%) 20/44 (46%) 20/46 (44%)
†Proportions of positive responses to PHA were significantly reduced in late compared to both early pregnancy and postpartum (P < 0·01).
‡Proportions of positive responses to PPD were reduced in early and late pregnancy compared to postpartum (P < 0·01). §Proportion of IFN- γ
responses to PPD was further reduced in late compared to early pregnancy (P < 0·001). Statistical analysis was by Z-test of proportions.
S. E. Cox et al.
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an association between TNF-α responses and peripheral
parasitaemia (34/91) at postpartum (P = 0·80).
Mitogen-induced cytokine production is positively 
correlated with plasma retinol concentration at 
enrolment in early pregnancy
To determine whether vitamin A status at enrolment, as
measured by plasma retinol, affected cellular immune
responses, PHA-induced cytokine responses at enrolment
(early pregnancy) were compared with baseline plasma ret-
inol concentrations. Although we did not measure plasma
concentrations of markers of the acute phase response,
which is known to be associated with decreased plasma ret-
inol concentrations [31], there was no evidence of a relation-
ship between plasma retinol and either reported morbidity
in the previous 2 days, increased temperature (> 37·4°C) or
peripheral parasitaemia (data not shown) to suggest that
infection was likely to confound the relationship between
plasma retinol and cytokine responses. Other possible con-
founding factors including baseline nutritional status (as
assessed by mean upper arm circumference), level of educa-
tion, urban or rural area of residence or season (high or low
malaria transmission) were investigated, but no evidence
was found of associations with cytokine responses. After
controlling for age (which was significantly positively asso-
ciated with IFN-γ and IL-10 responses) and peripheral par-
asitaemia in all models, plasma retinol concentration was
positively and significantly associated with IFN-γ and IL-10
mitogen-induced cytokine responses. For every 0·01 µg/dl
increase in plasma retinol, IFN-γ production increased by
3·5% (P = 0·002), IL-10 production increased by 1·3%
(P = 0·04) while for TNF-α there was no significant increase
(P = 0·18). In addition, plasma retinol was also positively
associated with the ratio of IFN-γ : IL-10 (P = 0·05).
At enrolment, very few PPD-induced responses were
above the LLD and the only cytokine for which there were
sufficient data points for analysis was IFN-γ (55/90 > LLD),
which when analysed by logistic regression did not show any
significant association with plasma retinol concentration
[odds ratio (OR) = 0·68, P = 0·42] or peripheral parasi-
taemia (OR = 0·82, P = 0·72). Furthermore, IFN-γ responses
to PPD were not associated with presence or absence of a
bacille–Calmette–Guérin (BCG) scar (OR = 1·42, P = 0·42).
Vitamin A supplementation increases the ratios of 
proinflammatory to anti-inflammatory cytokine 
responses
Comparisons of cytokine responses between the vitamin A
and placebo group were analysed as ratios of proinflamma-
tory to anti-inflammatory cytokines. Cytokine ratios had
been shown previously to be more informative than absolute
levels [30], and comparison of ratios avoided differences in
cytokine responses being due to possible effects of vitamin ATa
bl
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supplementation on the numbers of leucocytes in whole
blood cultures, rather than effects on cytokine production
per se.
At enrolment, as expected, geometric mean PHA-
induced cytokine concentrations and PHA-induced cytok-
ine ratios were similar in the two treatment groups (Table
4). In response to PPD, the prevalence of IFN-γ responses to
PPD did not differ between the vitamin A and placebo
groups, while 99% of TNF-α responses and 95% of IL-10
responses were below the LLD and could not be analysed
(Table 4).
We tested for an effect of vitamin A supplementation on
cytokine responses in pregnancy and at postpartum com-
pared to late pregnancy. Level of education (unevenly dis-
tributed between the vitamin A and placebo groups) and
presence of peripheral parasitaemia were included a priori in
multivariable models. Other variables that were determined
to have a significant effect in some models included baseline
nutritional status [as determined by body mass index (BMI)]
and place of residence (urban or rural), and these were thus
included in all models.
We examined the effect of vitamin A supplementation on
the ratios of proinflammatory IFN-γ and TNF-α to the anti-
inflammatory cytokine IL-10 (Table 5). The ratio of IFN-γ to
IL-10 production was significantly higher in the vitamin A-
supplemented group compared to the placebo group in late
pregnancy and at postpartum (61% and 57%). The ratio of
TNF-α : IL-10 was also higher in the vitamin A-supple-
mented group at both time-points, but did not reach statis-
tical significance (90% and 57% increases, respectively).
Discussion
The purpose of this study was to determine whether vitamin
A deficiency, or conversely vitamin A supplementation, was
associated with altered immune function in a cohort of
primigravid African women at high risk of both vitamin A
deficiency and infection by a number of intracellular
pathogens, including malaria and tuberculosis. Cytokine
responses measured in whole blood assays confirmed and
extended previous reports that antigen-specific cell-
mediated immune responses are down-regulated during
Table 4. Geometric mean cytokine ratios in response to stimulation of whole blood with phytohaemagglutinin (PHA) in the placebo and vitamin A 
supplemented groups.1
Geometric mean cytokine ratios (95% CI)
Placebo group Vitamin A supplemented group
IFN-γ : IL-10 TNF-α : IL-10 IFN-γ : TNF-α IFN-γ : IL-10 TNF-α : IL-10 IFN-γ : TNF-α
Early pregnancy 25·8 0·68 42·3 28·9 0·70 65·3
(19·9- 5·33) (0·51–0·91) (28·3–63·2) (22·8–36·8) (0·50–0·97) (42·9–99·5)
Late pregnancy 20·5 0·42 62·3 28·9 0·50 67·7
(15·4–27·2) (0·31–0·57) (44·3–87·5) (21·4–39·2) (0·34–0·73) (43·1–106·2)
Postpartum 48·6 0·50 113·7 53·5 0·94 95·0
(37·3–63·5) (0·36–0·70) (71·9–179·9) (41·7–68·8) (0·60–1·50) (68·5–131·8)
1Ratios were calculated only for samples within the detection limits. LLD: lower limit of detection. ULD: upper limit of detection. Numbers of
total samples tested varied between the cytokines and time-points due to some samples having insufficient volumes for complete testing.
Table 5. Effect of vitamin A supplementation on ratios of geometric mean cytokine production 
in response to stimulation with phytohaemagglutinin at late pregnancy (compared to early preg-
nancy) and postpartum (compared to late pregnancy).1
Time Cytokine ratio % change (95% CI) P-value
Late pregnancy adjusted for early IFN-γ : IL-10 (n = 59) +61% (+1%/+257%) P = 0·045
pregnancy and other possible TNF-α : IL-10 (n = 32) +56% (−10%/+257%) P = 0·11
confounders and co-factors2
Postpartum adjusted for late IFN-γ : IL-10 (n = 58) +57% (−1%/+244%) P = 0·043
pregnancy and other possible TNF-α : IL-10 (n = 28) +90% (−13%/+414%) P = 0·10
confounders and co-factors2
1Analysis by linear regression of ratios of log-transformed cytokine responses, calculated for
supernatants with concentrations within the detection limits of the assays. 2Level of education
(unevenly distributed between the vitamin A and placebo groups), and presence of peripheral
parasitaemia were included a priori in multivariate models. Other variables that were determined
to have a significant effect in some models included: baseline nutritional status as determined by
body mass index and place of residence, urban or rural, and were consequently included in all
models.
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pregnancy but that non-specific (mitogen-induced)
responses affected are less severely [21,22,32] These data also
support the hypothesis that pregnancy induces a bias
towards anti-inflammatory cytokine responses, as IFN-γ and
TNF-α responses were more severely suppressed than IL-10
responses and ratios of IFN-γ : IL-10 and TNF-α : IL-10
were significantly reduced during pregnancy. Furthermore,
our results suggest that vitamin A supplementation of sub-
clinically vitamin A-deficient women during pregnancy and
the postpartum period may increase the production of the
proinflammatory cytokine IFN-γ (and possibly TNF-α) and
decrease production of the anti-inflammatory cytokine IL-
10, resulting in significant skewing of the immune response
towards a type 1 cytokine balance during both pregnancy
and the postpartum period.
The observation that IFN-γ production was suppressed
more severely during pregnancy than was TNF-α produc-
tion may indicate that macrophages, an important source of
TNF-α, are affected less by pregnancy than are T cells and
natural killer (NK) cells, which are the major sources of IFN-
γ. In addition, as the decrease in the ratio between TNF-α
and IL-10 was only significantly reduced in late pregnancy it
appears that TNF-α is not suppressed until later in preg-
nancy; this is consistent with reports that TNF-α plays an
important role in placentation early in pregnancy [33].
Importantly, the observation that lower TNF-α responses in
late pregnancy were associated with increased risk of malar-
ial parasitaemia confirms previous reports of the relation-
ship between cytokine production and risk of malaria
infection [30], and supports the notion that suppression of
proinflammatory cytokine responses during pregnancy
might increase the mother’s susceptibility to infection.
The hypothesis that vitamin A status influences cellular
immune function is strongly supported by the significant
positive associations between plasma retinol concentration
and production of IFN-γ and IL-10 at baseline. Furthermore,
vitamin A supplementation led to skewing of the cytokine
response, significantly increasing the ratios of IFN-γ to IL-10
(and tending to increase ratios of TNF-α : IL-10) during
pregnancy and postpartum. Thus, contrary to some animal
studies [1,34,35], and studies in immunocompromised
humans [11,12], our data suggest that vitamin A supplemen-
tation tips the balance of cytokine responses towards
proinflammatory rather than anti-inflammatory immune
responses. The differences between our data and those pub-
lished previously might be explained by physiological differ-
ences between study populations (pregnant or not), extent of
vitamin A deficiency prior to supplementation and presence
or absence of concurrent infections. Our results are however,
consistent with those of Wieringa et al. [15] who reported
vitamin A deficiency to be associated with decreased IFN-γ
responses after mitogen stimulation in Indonesian children,
and Allende et al. [36], who found enhanced IFN-γ and IL-2
transcription and enhanced expression of cell surface activa-
tion markers in human PBMCs cultured with retinol.
Furthermore, our results fit with data from studies in mice,
in which vitamin A deficiency was associated with decreased
proportions of IFN-γ and IL-2 positive T cells and increased
proportions of IL-10 positive T cells [37]. Also, other studies
have demonstrated decreased delayed-type hypersensitivity
(DTH) responses in vitamin A-deficient rats [38,39],
increased PPD-induced IL-2 production and enhanced DTH
responses in vitamin A-supplemented M. bovis-infected
mice [40], enhanced cell-mediated responses to tetanus tox-
oid, diptheria and PPD in Bangladeshi infants receiving vita-
min A supplementation at the time of vaccination [41] and
enhanced Th-1-dependent, IgG1 antibody responses to tet-
anus toxoid in children receiving vitamin A supplementation
[42].
Potentiation of type 1 (proinflammatory) responses dur-
ing pregnancy is, potentially, a double-edged sword. While
stronger Th-1 responses might reduce the risk of infection
during pregnancy, providing protection against opportunis-
tic viral, bacterial and protozoal infections that target the
placenta and/or the developing fetus, inappropriate over-
production of type 1 cytokines may cause placental damage
and threaten the viability of the fetus and the mother [43–
45]. Alternatively, in mouse models, insufficient IFN-γ pro-
duction at the materno–fetal interface has been associated
with poor placental maturation and modification of the
uterine spiral arteries, leading to fetal loss [46,47]. The ten-
dency for vitamin A supplementation during pregnancy to
tip the cytokine balance towards type 1 responses suggests
that care must be taken to evaluate the potential deleterious
side effects of this intervention. However, in this study the
dose of vitamin A was low (equivalent to <4 days recom-
mended safe intake [48]) and no adverse effects on fetal and
infant survival or on preterm birth were observed in a similar
low-dose maternal vitamin A supplementation trial [49].
One potential confounder of the effect of vitamin A sup-
plementation on cytokine responses is maternal infection,
which might potentiate Th-1-like responses. In this commu-
nity, placental malaria infection is common and 87% of the
women in this study showed evidence of past or current pla-
cental malaria infection by histology [24]. We were unable to
measure malaria-specific cytokine responses, as the whole
blood assay used here is not suitable for detecting T cell
responses to malaria parasites [50] but we did not find any
difference in PHA-induced or PPD-induced cytokine pro-
duction between women who showed evidence of placental
malaria and those without. However, the presence of periph-
eral malarial parasitaemia in late pregnancy was associated
with low ratios of Th-1 to Th-2/3 cytokines and we did find
weak evidence to suggest that vitamin A supplementation
reduces the risk of chronic placental malaria infection [24],
suggesting that potentiation of type 1 responses may
enhance anti-malarial immunity in pregnancy.
In conclusion, this study has shown that vitamin A
supplementation in a subclinically vitamin A-deficient
population of primigravid African women increases
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proinflammatory cytokine responses during pregnancy and
during the postpartum period. These findings, especially
when taken together with the data on peripheral and placental
malaria infection, suggest that in countries with a high prev-
alence of subclinical vitamin A deficiency, low-dose vitamin
A supplementation has the potential to improve pregnancy
outcomes by enhancing resistance to pregnancy-associated
infections. Given the low cost and ease of distribution, vita-
min A supplementation may represent a cost-effective inter-
vention to improve maternal health in low-income countries.
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